Healgen Scientific

Healgen Scientific will showcase a wide range of diagnostic solutions at the Association for Diagnostics & Laboratory Medicine 2026 tradeshow, ADLM 2026, highlighting technologies designed to support laboratories, clinics, and point-of-care settings across human and veterinary testing. Read the article to learn more about Healgen's presence at the show: https://lnkd.in/g8gArdEY

Respiratory season continues to challenge care teams across the world with overlapping symptoms from COVID19, influenza A, and influenza B. The Healgen® Rapid Check® COVID19/Flu A&B Antigen Test Pro is a 3-in-1 lateral flow assay that qualitatively detects and differentiates SARSCoV2, Flu A, and Flu B from a single anterior nasal swab. Designed for professional use, this point-of-care test delivers visual results in 15 minutes, helping providers triage symptomatic patients and make timely decisions on treatment, isolation, and follow-up testing. By consolidating three targets into one test, organizations can reduce repeat swabbing, reduce hands-on time, and streamline respiratory testing workflows. Explore how the Healgen® Rapid Check® COVID19/Flu A&B Antigen Test Pro can support your respiratory testing strategy. Find the link in the comments below. 

We’re hiring! If you’re ready to make an impact in the world of diagnostics, we want to hear from you. ➡️ Marketing Communication Manager ➡️ Product Specialist – Immunoassays ➡️ Accounting Manager ➡️ Maintenance Engineer ➡️ Sales Representative - LAB Check out our latest openings below and apply today at healgen.com/careers/

The Association for Diagnostics & Laboratory Medicine 2026 tradeshow is almost here! We're excited to meet everyone who's attending and can't wait to see you there. If you're attending, stop by booth #1427 to say hello, learn about some of our newest products and devices, and even get a giveaway or two!

For many people, respiratory ailments are associated with colder months, when flu season dominates headlines and families brace for winter sickness. However, recent data has revealed a surprising and consistent trend: COVID-19 cases in the United States have surged during the summer months, particularly in August, for the past four years. In fact, these summer spikes have often outpaced more predictable winter increases in respiratory viruses. Read the rest of the article here: https://lnkd.in/gTagDCzX

Summer respiratory illnesses continue to challenge care teams across the world with overlapping symptoms from COVID19, influenza A, and influenza B. The Healgen® Rapid Check® COVID19/Flu A&B Antigen Test Pro is a 3-in-1 lateral flow assay that qualitatively detects and differentiates SARSCoV2, Flu A, and Flu B from a single anterior nasal swab. Designed for professional use, this point-of-care test delivers visual results in 15 minutes, helping providers triage symptomatic patients and make timely decisions on treatment, isolation, and follow-up testing. By consolidating three targets into one test, organizations can reduce repeat swabbing, reduce hands-on time, and streamline respiratory testing workflows. Explore how the Healgen® Rapid Check® COVID19/Flu A&B Antigen Test Pro can support your respiratory testing strategy. Find the link in the comments below.

Portfolio expansion starts with products that support speed, flexibility, and clinical relevance. Healgen’s Fecal Occult Blood (FOB)/Transferrin* combination test is a rapid chromatographic immunoassay for the qualitative detection of human blood as an aid in the diagnosis of gastrointestinal bleeding disorders. This product line gives distributors a practical screening solution to bring to their healthcare customers. Learn more about this product in the link in the comments. *Not for sale in the U.S. 

WHX was such a great opportunity for Healgen to connect with industry professionals, have meaningful conversations, and showcase some of our newest products. We always value the chance to meet new people, strengthen relationships, and share what we’ve been working on. Events like this are such a great reminder of how valuable in-person connection can be. What was the highlight of your recent event experience?

As respiratory season drives increased testing demand across much of South America, distributors have a key opportunity to expand access to reliable testing solutions. Healgen offers visually read, multi-analyte lateral flow assays to support timely testing in various scenarios with the Healgen® Rapid Check® COVID-19/Flu A&B Antigen Test or the Healgen® COVID-19+Flu A&B+RSV Ag Combo Rapid Test Cassette (Swab). With simple collection and results available in minutes, these products align with growing consumer or patient expectations for speed and accessibility in testing. With evolving market needs, adding these respiratory tests to your portfolio can support overall growth. Learn more by clicking the link in the comments below. 

One of the biggest men’s health concerns is cardiovascular disease. Nearly one-third of men have two or more risk factors, and heart disease remains one of the leading causes of death among men.¹  Tools that help monitor inflammation and support broader cardiovascular risk awareness can be a valuable complement to routine medical care. Healgen’s CRP C-Reactive Protein Semi-Quantitative Test* is designed to aid in evaluating the risks of cardiovascular disease.  Learn more about Healgen’s CRP C-Reactive Protein Semi-Quantitative Test in the comments. *Not for sale in the U.S. References:  1. Couch CA, Mascarenhas R, Stierman B, Fryar CD. Prevalence of cardiovascular disease risk factors in adults: United States, August 20221 – August 2023. NCHS Data Brief. 2025 Sep;(540):1-9. DOI https://lnkd.in/gBeJiHDZ.